Squarepoint’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-30,017
| Closed | -$566K | – | 2847 |
|
2019
Q3 | $566K | Buy |
+30,017
| New | +$566K | 0.01% | 1500 |
|
2019
Q2 | – | Sell |
-25,596
| Closed | -$349K | – | 2725 |
|
2019
Q1 | $349K | Sell |
25,596
-13,357
| -34% | -$182K | ﹤0.01% | 1643 |
|
2018
Q4 | $399K | Sell |
38,953
-5,782
| -13% | -$59.2K | ﹤0.01% | 1358 |
|
2018
Q3 | $745K | Buy |
44,735
+20,780
| +87% | +$346K | 0.01% | 1125 |
|
2018
Q2 | $378K | Sell |
23,955
-131,756
| -85% | -$2.08M | 0.01% | 1286 |
|
2018
Q1 | $1.98M | Buy |
155,711
+124,353
| +397% | +$1.58M | 0.03% | 579 |
|
2017
Q4 | $359K | Buy |
+31,358
| New | +$359K | 0.01% | 1384 |
|
2016
Q1 | – | Sell |
-13,900
| Closed | -$459K | – | 1577 |
|
2015
Q4 | $459K | Buy |
+13,900
| New | +$459K | 0.05% | 581 |
|
2015
Q3 | – | Sell |
-6,300
| Closed | -$334K | – | 641 |
|
2015
Q2 | $334K | Buy |
+6,300
| New | +$334K | 0.11% | 270 |
|